Antibody Response to Trivalent Influenza Vaccine in the Northern and the Southern Hemisphere in Elite Athletes

Author(s):  
Jarosław Krzywański ◽  
Aneta Nitsch-Osuch ◽  
Tomasz Mikulski ◽  
Hubert Krysztofiak ◽  
Andrzej Pokrywka ◽  
...  
2015 ◽  
Vol 11 (2) ◽  
pp. 386-390 ◽  
Author(s):  
Satoshi Hiroi ◽  
Saeko Morikawa ◽  
Keiko Nakata ◽  
Akiko Maeda ◽  
Tsuneji Kanno ◽  
...  

1986 ◽  
Vol 96 (3) ◽  
pp. 513-522 ◽  
Author(s):  
Walter E. P. Beyer ◽  
Jos T. M. Van Der Logt ◽  
Ruud van Beek ◽  
Nic Masurel

SUMMARYFifty volunteers, treated with an inactivated trivalent influenza vaccine containing A/Bangkok/1/79 (H3N2), A/Brazil/11/78 (H1N1) and B/Singapore/222/79 virus, were subdivided according to the estimated first exposure to influenza in their lifetime (priming) and the presence of antibodies against the vaccine components in the pre-vaccination sera. The isotypic antibody response (IgG, IgA, IgM) was determined by means of an antibody capture haemadsorption immunosorbent technique. For all three vaccine components, previously seropositive subjects produced antibodies of the IgG- and IgA-class more frequently than previously seronegative persons. Subjects primed to one of the influenza A subtypes showed more IgG and IgA responses in comparison with those unprimed (prime-effect). In contrast, IgM antibodies occurred in only 19 and 11% of primed, but in 59 and 54% of unprimed subjects, for A (H3N2) and A (HlNl), respectively. The incidence of IgM titre rises was not influenced by the prevaccination state. However, the mean magnitude of anti-A(H1N1)-IgM titre rises was greater in those previously seronegative. The concepts of primary and reinfection and of ‘original antigenic sin’ are discussed, and it is suggested that age and, if possible, serological state prior to antigen-exposure should be taken into account when studying isotypic antibody responses after influenza infection or vaccination.


2019 ◽  
Vol 70 (11) ◽  
pp. 2432-2434 ◽  
Author(s):  
Sigrid Gouma ◽  
Madison Weirick ◽  
Scott E Hensley

Abstract Here, we find that the egg-adapted H3N2 component of the 2019 Southern Hemisphere influenza vaccine elicits an antibody response in ferrets that is highly focused on antigenic site A of hemagglutinin. This is potentially problematic as most H3N2 viruses currently circulating in the Southern Hemisphere possess antigenic site A substitutions.


Vaccine ◽  
2014 ◽  
Vol 32 (30) ◽  
pp. 3869-3876 ◽  
Author(s):  
Steve Rockman ◽  
Dorit Becher ◽  
Allison Dyson ◽  
Sandra Koernig ◽  
Adriana Baz Morelli ◽  
...  

2019 ◽  
Author(s):  
Sigrid Gouma ◽  
Madison Weirick ◽  
Scott E. Hensley

AbstractHere, we find that the egg-adapted H3N2 component of the 2019 Southern Hemisphere influenza vaccine elicits an antibody response in ferrets that is highly focused on antigenic site A of hemagglutinin. This is potentially problematic since most H3N2 viruses currently circulating in the Southern Hemisphere possess antigenic site A substitutions.


Sign in / Sign up

Export Citation Format

Share Document